Întreruperea tratamentului cu GLP-1, asociată cu dublarea riscului de infarct, AVC sau deces la pacienții cu diabet G4Food.ro 8h
Nvidia CEO Jensen Huang says AI's 'Most profound impact' will be in life sciences -- and Eli Lilly is already building on it The Motley Fool 7h Eli Lilly Nvidia Top Tech Brands
FDA quietly shelves Trump’s flagship drug fast-track program The Independent 13h Donald Trump FDA Article paywall
Doctors are exposing the most unusual, "I didn't even know that existed" conditions they've had to treat, and honestly, I'm never complaining about a cold again BuzzFeed 13h Australian Health
